marketcaparena
Search

    KROS

    Keros Therapeutics, Inc.

    Company overview

    Market capitalization
    $223.65M
    Employees
    87
    Latest publication
    2026-09-29
    About Keros Therapeutics, Inc.

    Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. It develops rinvatercept, which acts as a ligand trap and inhibits the biological effects of myostatin and activin A in Phase 1 clinical trials for Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis; and elritercept to target TGF-ß signaling pathways to address diseases that arise from ineffective hematopoiesis in Phase 3 clinical trials for Myelodysplastic Syndromes and Phase 2 clinical trials for Myelofibrosis. The company has collaboration and license agreements with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept; and Takeda Pharmaceuticals U.S.A., Inc. to develop, manufacture, and commercialize elritercept and certain derivative compounds. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue0USD367,000USD385,000USD14,262,000USD18,168,000USD211,246,000USD3,042,000USD388,000USD
    Research Development22,331,000USD16,097,000USD17,912,000USD19,519,000USD43,503,000USD48,709,000USD45,631,000USD49,225,000USD
    General And Administrative Expenses8,606,000USD———————
    Total Operating Expenses30,937,000USD25,841,000USD29,655,000USD29,251,000USD57,615,000USD59,206,000USD55,964,000USD58,731,000USD
    Operating Income-30,937,000USD-25,877,000USD-29,270,000USD-15,384,000USD-39,817,000USD152,040,000USD-53,254,000USD-58,657,000USD
    Total Other Income Expense Net2,227,000USD2,169,000USD4,295,000USD6,680,000USD6,899,000USD6,454,000USD7,528,000USD5,701,000USD
    Income Before Tax-28,710,000USD-23,708,000USD-24,975,000USD-8,704,000USD-32,918,000USD158,494,000USD-45,726,000USD-52,956,000USD
    Income Tax Expense0USD—-1,514,000USD-1,424,000USD-2,222,000USD10,043,000USD300,000USD—
    Net Income-28,710,000USD-23,708,000USD-23,461,000USD-7,280,000USD-30,696,000USD148,451,000USD-46,026,000USD-52,956,000USD
    Net Income Applicable To Common Shares-28,710,000USD———————
    Cost Of Revenue—403,000USD400,000USD395,000USD370,000USD344,000USD332,000USD314,000USD
    Gross Profit—-36,000USD385,000USD13,867,000USD17,798,000USD211,246,000USD2,710,000USD74,000USD
    Selling General Administrative—10,147,000USD11,743,000USD10,127,000USD14,482,000USD10,497,000USD10,665,000USD9,820,000USD
    Tax Provision—0USD-1,514,000USD-1,424,000USD-2,222,000USD10,043,000USD——
    Net Income From Continuing Ops—-23,708,000USD-23,461,000USD-7,280,000USD-30,696,000USD148,451,000USD-46,026,000USD-52,956,000USD
    Ebit—-23,708,000USD-24,975,000USD-8,704,000USD-32,918,000USD158,494,000USD-29,474,000USD-52,956,000USD
    Ebitda—-23,305,000USD-24,575,000USD-8,309,000USD-32,548,000USD158,838,000USD-29,142,000USD-52,642,000USD
    Depreciation And Amortization—403,000USD400,000USD395,000USD370,000USD344,000USD332,000USD314,000USD
    Reconciled Depreciation—403,000USD400,000USD395,000USD370,000USD344,000USD332,000USD314,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue244,061,000USD3,550,000USD151,000USD20,000,000USD20,100,000USD2,500,000USD10,000,000USD10,000,000USD
    Cost Of Revenue1,509,000USD1,229,000USD815,000USD1,615,000USD898,000USD605,000USD17,348,000USD10,111,000USD
    Gross Profit242,552,000USD3,550,000USD151,000USD-1,615,000USD20,100,000USD-605,000USD-7,348,000USD-111,000USD
    Research Development129,643,000USD173,629,000USD135,258,000USD87,265,000USD55,143,000USD33,860,000USD17,379,000USD10,111,000USD
    Selling General Administrative46,849,000USD40,754,000USD34,834,000USD27,525,000USD21,330,000USD12,797,000USD3,184,000USD1,580,000USD
    Unclassified Operating Expenses-4,563,000USD———————
    Total Operating Expenses171,929,000USD214,383,000USD170,092,000USD114,790,000USD76,473,000USD46,052,000USD20,005,000USD11,321,000USD
    Operating Income70,623,000USD-210,833,000USD-169,941,000USD-114,790,000USD-56,373,000USD-46,657,000USD-10,563,000USD-1,691,000USD
    Income Before Tax91,897,000USD-187,053,000USD-152,992,000USD-104,679,000USD-56,733,000USD-45,533,000USD-12,336,000USD-1,078,000USD
    Income Tax Expense4,883,000USD300,000USD-206,000USD1,000USD2,011,000USD-172,000USD8,000USD257,000USD
    Tax Provision4,883,000USD300,000USD0USD1,999,000USD2,011,000USD-172,000USD-172,000USD257,000USD
    Net Income87,014,000USD-187,353,000USD-152,992,000USD-104,679,000USD-58,744,000USD-45,361,000USD-12,344,000USD-1,335,000USD
    Net Income From Continuing Ops87,014,000USD-187,353,000USD-152,992,000USD-104,679,000USD-58,744,000USD-45,361,000USD-12,336,000USD-1,335,000USD
    Ebit91,897,000USD-187,053,000USD-152,992,000USD-104,678,000USD-56,729,000USD-45,527,000USD-12,328,000USD-1,078,000USD
    Ebitda93,406,000USD-185,824,000USD-152,177,000USD-104,004,000USD-56,351,000USD-44,922,000USD-11,890,000USD-774,000USD
    Depreciation And Amortization1,509,000USD1,229,000USD815,000USD674,000USD378,000USD605,000USD438,000USD304,000USD
    Reconciled Depreciation1,509,000USD1,229,000USD815,000USD674,000USD378,000USD278,000USD208,000USD153,000USD
    Total Other Income Expense Net21,274,000USD23,780,000USD16,949,000USD10,111,000USD-360,000USD1,124,000USD-1,773,000USD613,000USD
    Interest Expense—0USD0USD1,000USD4,000USD6,000USD8,000USD6,000USD
    Net Interest Income—0USD0USD-1,000USD-4,000USD-6,000USD-8,000USD6,000USD
    Non Operating Income Net Other———10,112,000USD-356,000USD1,130,000USD——
    Net Income Applicable To Common Shares———-104,679,000USD-58,744,000USD-45,361,000USD-14,136,000USD-2,346,000USD
    Interest Income——————2,572,000USD37,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets287,600,000USD312,293,000USD338,021,000USD742,783,000USD757,165,000USD784,561,000USD615,886,000USD579,271,000USD
    Cash And Equivalents257,606,000USD———————
    Total Current Assets266,883,000USD290,677,000USD315,434,000USD719,307,000USD732,808,000USD759,509,000USD588,893,000USD552,046,000USD
    Other Current Assets7,027,000USD6,216,000USD21,647,000USD20,270,000USD24,854,000USD19,594,000USD24,506,000USD19,439,000USD
    Total Liabilities25,280,000USD———————
    Total Current Liabilities12,153,000USD12,853,000USD20,414,000USD24,092,000USD34,707,000USD39,379,000USD27,450,000USD29,007,000USD
    Other Current Liabilities7,740,000USD———————
    Total Stockholder Equity262,320,000USD285,630,000USD303,132,000USD703,580,000USD706,734,000USD728,871,000USD571,553,000USD532,835,000USD
    Total Equity Including Noncontrolling Interest262,320,000USD———————
    Net Receivables0USD2,964,000USD6,372,000USD5,565,000USD17,739,000USD19,374,000USD4,456,000USD1,923,000USD
    Property Plant Equipment Net19,268,000USD20,167,000USD21,138,000USD22,027,000USD22,908,000USD23,140,000USD23,488,000USD24,189,000USD
    Accounts Payable1,816,000USD1,493,000USD1,967,000USD2,298,000USD5,267,000USD6,636,000USD4,602,000USD4,981,000USD
    Short Term Debt2,597,000USD2,501,000USD2,408,000USD2,318,000USD2,230,000USD2,102,000USD1,978,000USD1,857,000USD
    Common Stock4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Retained Earnings-534,183,000USD-505,473,000USD-481,765,000USD-458,304,000USD-451,024,000USD-420,328,000USD-568,779,000USD-522,753,000USD
    Total Liab—26,663,000USD34,889,000USD39,203,000USD50,431,000USD55,690,000USD44,333,000USD46,436,000USD
    Other Current Liab—8,859,000USD16,039,000USD19,321,000USD19,964,000USD17,290,000USD20,870,000USD22,169,000USD
    Capital Stock—4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Cash—281,497,000USD287,415,000USD693,472,000USD690,215,000USD720,541,000USD559,931,000USD530,684,000USD
    Cash And Short Term Investments—281,497,000USD287,415,000USD693,472,000USD690,215,000USD720,541,000USD559,931,000USD530,684,000USD
    Net Debt—-265,186,000USD-270,532,000USD-676,043,000USD-672,261,000USD-702,128,000USD-541,070,000USD-511,398,000USD
    Short Long Term Debt Total—16,311,000USD16,883,000USD17,429,000USD17,954,000USD18,413,000USD18,861,000USD19,286,000USD
    Property Plant Equipment Gross—20,167,000USD25,573,000USD22,027,000USD22,908,000USD23,140,000USD26,437,000USD24,189,000USD
    Common Stock Shares Outstanding—37,859,106shares37,859,106shares40,623,364shares40,612,907shares41,021,000shares40,338,000shares36,103,000shares
    Non Current Assets Total—21,616,000USD22,587,000USD23,476,000USD24,357,000USD25,052,000USD26,993,000USD27,225,000USD
    Non Current Liabilities Total—13,810,000USD14,475,000USD15,111,000USD15,724,000USD16,311,000USD16,883,000USD17,429,000USD
    Non Currrent Assets Other—1,449,000USD1,449,000USD1,449,000USD1,449,000USD463,000USD2,056,000USD1,587,000USD
    Net Working Capital—277,824,000USD295,020,000USD695,215,000USD698,101,000USD720,130,000USD561,443,000USD523,039,000USD
    Unclassified Non Current Liabilities—13,810,000USD14,475,000USD15,111,000USD15,724,000USD16,311,000USD16,883,000USD17,429,000USD
    Unclassified Equity—791,095,000USD784,889,000USD1,161,876,000USD1,157,750,000USD1,149,191,000USD1,140,324,000USD1,055,580,000USD
    Current Deferred Revenue———155,000USD925,000USD3,308,000USD——
    Unclassified Current Liabilities————6,321,000USD10,043,000USD——
    Unclassified Non Current Assets—————1,449,000USD1,449,000USD1,449,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets338,021,000USD615,886,000USD370,025,000USD306,781,000USD255,251,000USD269,443,000USD10,955,000USD27,412,000USD
    Other Current Assets21,647,000USD24,506,000USD15,055,000USD5,878,000USD3,201,000USD1,634,000USD226,000USD84,000USD
    Total Liab34,889,000USD44,333,000USD37,812,000USD29,358,000USD12,077,000USD7,722,000USD5,504,000USD14,654,000USD
    Total Stockholder Equity303,132,000USD571,553,000USD332,213,000USD277,423,000USD243,174,000USD261,721,000USD5,451,000USD12,758,000USD
    Other Current Liab16,039,000USD20,870,000USD17,918,000USD12,703,000USD7,229,000USD4,427,000USD107,000USD802,000USD
    Common Stock4,000USD4,000USD3,000USD2,000USD2,000USD2,000USD2,000USD1,000USD
    Capital Stock4,000USD4,000USD3,000USD2,000USD2,000USD2,000USD2,000USD19,942,000USD
    Retained Earnings-481,765,000USD-568,779,000USD-381,426,000USD-228,434,000USD-123,755,000USD-65,011,000USD-19,650,000USD-7,314,000USD
    Cash287,415,000USD559,931,000USD331,147,000USD279,048,000USD230,042,000USD265,876,000USD7,020,000USD23,259,000USD
    Cash And Short Term Investments287,415,000USD559,931,000USD331,147,000USD279,048,000USD230,042,000USD265,876,000USD7,020,000USD23,259,000USD
    Total Current Assets315,434,000USD588,893,000USD347,293,000USD285,767,000USD251,440,000USD267,726,000USD8,927,000USD25,531,000USD
    Total Current Liabilities20,414,000USD27,450,000USD24,373,000USD16,547,000USD11,846,000USD7,184,000USD4,486,000USD11,469,000USD
    Net Debt-270,532,000USD-541,070,000USD-316,703,000USD-265,782,000USD-228,949,000USD-264,977,000USD-5,745,000USD-22,471,000USD
    Short Term Debt2,408,000USD1,978,000USD1,005,000USD455,000USD862,000USD423,000USD376,000USD166,000USD
    Short Long Term Debt Total16,883,000USD18,861,000USD14,444,000USD13,266,000USD1,093,000USD899,000USD5,332,000USD2,558,000USD
    Net Receivables6,372,000USD4,456,000USD1,091,000USD841,000USD18,197,000USD216,000USD922,000USD—
    Accounts Payable1,967,000USD4,602,000USD5,450,000USD3,339,000USD3,645,000USD2,149,000USD2,088,000USD501,000USD
    Property Plant Equipment Net21,138,000USD23,488,000USD19,468,000USD17,569,000USD2,402,000USD1,602,000USD1,913,000USD1,380,000USD
    Property Plant Equipment Gross25,573,000USD26,437,000USD21,188,000USD17,569,000USD2,402,000USD1,602,000USD1,913,000USD1,380,000USD
    Common Stock Shares Outstanding37,859,106shares37,438,000shares29,447,119shares25,241,030shares23,333,914shares15,506,397shares8,882,168shares8,882,168shares
    Non Current Assets Total22,587,000USD26,993,000USD22,732,000USD21,014,000USD3,811,000USD1,717,000USD2,028,000USD1,881,000USD
    Non Current Liabilities Total14,475,000USD16,883,000USD13,439,000USD12,811,000USD231,000USD538,000USD1,018,000USD3,185,000USD
    Non Currrent Assets Other1,449,000USD2,056,000USD2,052,000USD3,445,000USD1,409,000USD115,000USD115,000USD501,000USD
    Net Working Capital295,020,000USD561,443,000USD322,920,000USD269,220,000USD239,594,000USD260,542,000USD4,441,000USD14,062,000USD
    Unclassified Non Current Liabilities14,475,000USD16,883,000USD13,439,000USD———-4,176,000USD-1,941,000USD
    Unclassified Equity784,889,000USD1,140,324,000USD713,633,000USD505,853,000USD366,925,000USD596,171,000USD45,038,000USD—
    Unclassified Non Current Assets—1,449,000USD1,212,000USD-3,445,000USD-1,409,000USD———
    Current Deferred Revenue——17,253,000USD—7,135,000USD4,394,000USD1,915,000USD10,000,000USD
    Inventory——14,054,000USD-841,000USD3,058,000USD1,474,000USD759,000USD—
    Accumulated Other Comprehensive Income——0USD0USD0USD-269,443,000USD-19,941,000USD-246,000USD
    Unclassified Current Assets——-14,054,000USD—-3,058,000USD——2,188,000USD
    Unclassified Current Liabilities——-17,253,000USD—-7,025,000USD-4,209,000USD——
    Deferred Long Term Liab———400,000USD————
    Other Assets———3,445,000USD1,409,000USD993,000USD115,000USD501,000USD
    Non Current Liabilities Other———12,811,000USD231,000USD62,000USD119,000USD2,563,000USD
    Net Tangible Assets———277,423,000USD243,174,000USD261,721,000USD-19,446,000USD-7,183,000USD
    Other Liab—————62,000USD119,000USD171,000USD
    Long Term Debt——————4,956,000USD2,392,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-23,708,000USD-23,461,000USD-7,280,000USD-30,696,000USD148,451,000USD-46,026,000USD-52,956,000USD-45,257,000USD
    Depreciation403,000USD400,000USD395,000USD370,000USD344,000USD332,000USD314,000USD306,000USD
    Stock Based Compensation6,199,000USD7,305,000USD3,986,000USD8,542,000USD8,863,000USD9,200,000USD8,817,000USD8,785,000USD
    Other Non Cash Items636,000USD623,000USD609,000USD581,000USD584,000USD572,000USD563,000USD346,000USD
    Change To Account Receivables3,167,000USD-2,325,000USD12,324,000USD1,475,000USD-14,549,000USD-2,354,000USD-384,000USD222,000USD
    Change In Working Capital12,941,000USD-12,159,000USD5,539,000USD-8,420,000USD2,929,000USD-10,086,000USD12,762,000USD-3,981,000USD
    Total Cash From Operating Activities-3,529,000USD-27,292,000USD3,249,000USD-29,623,000USD161,171,000USD-46,008,000USD-30,500,000USD-39,801,000USD
    Capital Expenditures-73,000USD-134,000USD-132,000USD-720,000USD-565,000USD-289,000USD-386,000USD-310,000USD
    Free Cash Flow-3,602,000USD-27,426,000USD3,117,000USD-30,343,000USD160,606,000USD-46,297,000USD-30,886,000USD-40,111,000USD
    Total Cashflows From Investing Activities-73,000USD-134,000USD-132,000USD-720,000USD-565,000USD-289,000USD-386,000USD-310,000USD
    Total Cash From Financing Activities-2,316,000USD-378,631,000USD140,000USD17,000USD4,000USD75,544,000USD155,944,000USD3,531,000USD
    Change In Cash-5,918,000USD-406,057,000USD3,257,000USD-30,326,000USD160,610,000USD29,247,000USD125,058,000USD-36,580,000USD
    Begin Period Cash Flow287,415,000USD694,921,000USD691,664,000USD721,990,000USD561,380,000USD532,133,000USD407,075,000USD443,655,000USD
    End Period Cash Flow281,497,000USD288,864,000USD694,921,000USD691,664,000USD721,990,000USD561,380,000USD532,133,000USD407,075,000USD
    Other Cashflows From Financing Activities-2,323,000USD-378,758,000USD2,000USD—4,000USD2,445,000USD878,000USD2,902,000USD
    Issuance Of Capital Stock—-138,000USD138,000USD0USD0USD73,099,000USD155,066,000USD629,000USD
    Investments——-132,000USD-720,000USD-565,000USD-289,000USD-386,000USD-310,000USD
    Sale Purchase Of Stock——138,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income87,014,000USD-187,353,000USD-152,992,000USD-104,679,000USD-58,744,000USD-45,361,000USD-12,336,000USD-1,335,000USD
    Depreciation1,509,000USD1,229,000USD815,000USD674,000USD378,000USD278,000USD438,000USD153,000USD
    Stock Based Compensation28,696,000USD34,872,000USD28,763,000USD18,682,000USD11,722,000USD4,097,000USD59,000USD81,000USD
    Other Non Cash Items2,397,000USD1,820,000USD1,556,000USD953,000USD520,000USD1,817,000USD2,624,000USD194,000USD
    Change To Account Receivables-825,000USD-2,599,000USD-143,000USD18,000,000USD-18,000,000USD922,000USD-552,000USD-370,000USD
    Change In Working Capital-12,111,000USD-11,437,000USD-2,650,000USD14,308,000USD-16,070,000USD2,275,000USD-6,724,000USD7,949,000USD
    Total Cash From Operating Activities107,505,000USD-160,869,000USD-124,508,000USD-70,062,000USD-62,148,000USD-36,894,000USD-15,998,000USD7,042,000USD
    Capital Expenditures-1,551,000USD-1,931,000USD-2,464,000USD-1,241,000USD-1,024,000USD-294,000USD-270,999USD-217,000USD
    Free Cash Flow105,954,000USD-162,800,000USD-126,972,000USD-71,303,000USD-63,172,000USD-37,188,000USD-16,268,999USD6,825,000USD
    Total Cashflows From Investing Activities-1,551,000USD-1,931,000USD-2,464,000USD-1,241,000USD-1,024,000USD-294,000USD-271,000USD-217,000USD
    Total Cash From Financing Activities-378,470,000USD391,821,000USD178,956,000USD120,309,000USD28,550,000USD296,044,000USD14,000USD11,463,000USD
    Sale Purchase Of Stock-375,000,000USD0USD—120,309,000USD28,550,000USD299,013,000USD14,000USD11,508,000USD
    Issuance Of Capital Stock0USD380,134,000USD175,825,000USD119,578,000USD28,171,000USD299,202,000USD56,000,000USD11,500,000USD
    Change In Cash-272,516,000USD229,021,000USD51,984,000USD49,006,000USD-34,622,000USD258,856,000USD-16,239,000USD18,288,000USD
    Begin Period Cash Flow561,380,000USD332,359,000USD280,375,000USD231,369,000USD265,991,000USD7,135,000USD23,259,000USD5,102,000USD
    End Period Cash Flow288,864,000USD561,380,000USD332,359,000USD280,375,000USD231,369,000USD265,991,000USD7,020,000USD23,390,000USD
    Other Cashflows From Financing Activities-378,470,000USD11,687,000USD3,131,000USD731,000USD379,000USD52,842,000USD14,000USD11,463,000USD
    Unclassified Financing Cash Flow375,000,000USD380,134,000USD———-55,391,000USD—-11,508,000USD
    Investments—-1,931,000USD-2,464,000USD-1,241,000USD-1,024,000USD-294,000USD-271,000USD-217,000USD
    Unclassified Investing Cash Flow—1,931,000USD2,464,000USD1,241,000USD1,024,000USD———
    Change To Inventory——-4,505,000USD—1,042,000USD-922,000USD552,000USD—
    Change To Liabilities———4,914,000USD4,075,000USD61,000USD-8,688,000USD-10,002,000USD
    Cash And Cash Equivalents Changes———49,006,000USD-34,622,000USD258,856,000USD——
    Net Borrowings—————-420,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductLicense0USD0001664710-26-000030
    Q1 2026Quarterly · 2026-03-31ProductService Other367,000USD0001664710-26-000030
    FY 2025Yearly · 2025-12-31ProductLicense Revenue205,355,000USD0001664710-26-000018
    FY 2025Yearly · 2025-12-31ProductServices38,509,000USD0001664710-26-000018
    Q3 2025Quarterly · 2025-09-30ProductLicense10,000,000USD0001664710-25-000089
    Q3 2025Quarterly · 2025-09-30ProductService Other4,262,000USD0001664710-25-000089
    Q2 2025Quarterly · 2025-06-30ProductLicense0USD0001664710-25-000070
    Q2 2025Quarterly · 2025-06-30ProductService Other18,168,000USD0001664710-25-000070
    Q1 2025Quarterly · 2025-03-31ProductLicense195,355,000USD0001664710-26-000030
    Q1 2025Quarterly · 2025-03-31ProductService Other15,891,000USD0001664710-26-000030
    Q4 2024Quarterly · 2024-12-31ProductLicense3,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductService Other42,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductLicense3,000,000USD0001664710-26-000018
    FY 2024Yearly · 2024-12-31ProductService Other550,000USD0001664710-26-000018
    Q3 2024Quarterly · 2024-09-30ProductLicense0USD0001664710-25-000089
    Q3 2024Quarterly · 2024-09-30ProductService Other388,000USD0001664710-25-000089
    Q2 2024Quarterly · 2024-06-30ProductLicense0USD0001664710-25-000070
    Q2 2024Quarterly · 2024-06-30ProductService Other37,000USD0001664710-25-000070
    Q1 2024Quarterly · 2024-03-31ProductLicense0USD0001664710-25-000046
    Q1 2024Quarterly · 2024-03-31ProductService Other83,000USD0001664710-25-000046
    FY 2023Yearly · 2023-12-31ProductLicense0USD0001664710-25-000018
    FY 2023Yearly · 2023-12-31ProductService Other151,000USD0001664710-25-000018
    FY 2021Yearly · 2021-12-31ProductLicense20,100,000USD0001664710-24-000017
    FY 2021Yearly · 2021-12-31ProductService Other0USD0001664710-24-000017

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.